Aveanna Healthcare (NASDAQ:AVAH) issued an update on its FY 2021 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $- for the period. The company issued revenue guidance of $1.75 B-.
AVAH stock traded up $0.08 during mid-day trading on Thursday, reaching $12.68. The company’s stock had a trading volume of 19,048 shares, compared to its average volume of 1,101,061. Aveanna Healthcare has a fifty-two week low of $9.80 and a fifty-two week high of $13.00.
Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings data on Monday, May 24th. The company reported $0.08 EPS for the quarter, beating the Zacks’ consensus estimate of $0.07 by $0.01. On average, sell-side analysts expect that Aveanna Healthcare will post 0.43 earnings per share for the current year.
In related news, CFO David Afshar bought 4,284 shares of the stock in a transaction on Friday, April 30th. The shares were purchased at an average price of $11.67 per share, with a total value of $49,994.28. Following the purchase, the chief financial officer now owns 14,534 shares in the company, valued at $169,611.78. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
About Aveanna Healthcare
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals.
Featured Article: Are we seeing the beginning of a new bubble?
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.